These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 8050681)
1. [Hormone substitution beginning when, with what, how long?]. Breckwoldt M; Keck C Geburtshilfe Frauenheilkd; 1994 May; 54(5):M67-9. PubMed ID: 8050681 [No Abstract] [Full Text] [Related]
2. [Prevention of osteoporosis using estrogen and gestagens]. Lauritzen C Gynakologe; 1992 Feb; 25(1):31-5. PubMed ID: 1547979 [No Abstract] [Full Text] [Related]
3. [Estrogen-gestagen substitution in geriatric gynecology. Long-term prevention for the third segment of life after menopause]. Lauritzen C Fortschr Med; 1996 May; 114(15):187-90. PubMed ID: 8767936 [TBL] [Abstract][Full Text] [Related]
4. [Some problems of postmenopausal osteoporosis prevention with hormone replacement therapy]. Liu JL Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Jun; 25(3):240-3. PubMed ID: 12905731 [TBL] [Abstract][Full Text] [Related]
5. Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 3. Effects of ovarian hormone therapy on skeletal and extraskeletal tissues in women. Josse RG CMAJ; 1996 Oct; 155(7):929-34. PubMed ID: 8837542 [TBL] [Abstract][Full Text] [Related]
6. [Osteoporosis: prevention with postmenopausal hormonal substitution]. Welti H Rev Med Suisse Romande; 1990 Jun; 110(6):565-9. PubMed ID: 2367794 [No Abstract] [Full Text] [Related]
7. Long-term estrogen and hormone replacement therapy for the prevention and treatment of osteoporosis. Levine JP Curr Womens Health Rep; 2003 Jun; 3(3):181-6. PubMed ID: 12734027 [TBL] [Abstract][Full Text] [Related]
8. Etidronate and hormone replacement therapy (HRT) for postmenopausal women with osteoporosis despite HRT. Morishige K; Yamamoto T; Sawada K; Ohmichi M; Tasaka K; Murata Y Arch Gynecol Obstet; 2003 Jun; 268(2):105-6. PubMed ID: 12768299 [TBL] [Abstract][Full Text] [Related]
11. Comparative cardiovascular effects of different progestins in menopause. Rosano GM; Fini M Int J Fertil Womens Med; 2001; 46(5):248-56. PubMed ID: 11720197 [TBL] [Abstract][Full Text] [Related]
12. A practical guide to prescribing estrogen replacement therapy. Corson SL Int J Fertil Menopausal Stud; 1995; 40(5):229-47. PubMed ID: 8556028 [TBL] [Abstract][Full Text] [Related]
14. Prognostic features of menopausal and postmenopausal applicants for life insurance. Schiefeling M J Insur Med; 1996; 28(1):27-34. PubMed ID: 10172866 [TBL] [Abstract][Full Text] [Related]
15. Caution issued on hormone replacement therapy. FDA Consum; 2001; 35(5):7. PubMed ID: 11697101 [No Abstract] [Full Text] [Related]
16. [Right or wrong of the hormone replacement therapy involving osteoporosis]. Hoshino S; Ouchi Y Clin Calcium; 2004 Nov; 14(11):87-98. PubMed ID: 15577164 [TBL] [Abstract][Full Text] [Related]
17. [Pharmaco-economic evaluation of drug therapy osteoporosis. A literature review]. Christensen PM; Brøsen K; Brixen KT; Beck-Nielsen H; Søgaard J; Kristiansen IS Ugeskr Laeger; 2002 Mar; 164(10):1339-45. PubMed ID: 11894425 [TBL] [Abstract][Full Text] [Related]
18. Combination therapies for osteoporosis. Jamal SA J Am Pharm Assoc (2003); 2004; 44(2):119; author reply 119. PubMed ID: 15098843 [No Abstract] [Full Text] [Related]